In addition to acquiring the property, including all buildings and facilities, Omya intends to acquire Spirig Pharma's Cosmospheres business unit, which develops and manufactures cellulose-based additives for the cosmetics industry. According to Omya, in recent years, Oftringen headquarters in have grown substantially and have reached their capacity. With the relocation of research and development activities to neighboring Egerkingen, the bottleneck at the headquarters will be eliminated long-term without further construction and space will be made available for the company's strongly growing activities.
The buildings in Egerkingen have a modern technical infrastructure, which are suitable for research and development activities without substantial structural interventions. The Cosmospheres business unit, which Omya intends to acquire, would complement and expand Omya’s offering, as Omya already is a supplier of raw materials for the cosmetics and pharmaceutical industries. In the end, up to 350 full-time jobs will be located at the new site.
More info: Omya, Tel: (41) 62 789 29 29; Website: www.omya.com